Bioceres Crop Solutions (BIOX) News Today

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totalling 386,700 shares, a decline of 21.5% from the July 15th total of 492,300 shares. Based on an average trading volume of 58,300 shares, the short-interest ratio is currently 6.6 days. Currently, 1.3% of the company's shares are short sold.

Bioceres Crop Solutions (NASDAQ:BIOX) Sets New 12-Month Low at $10.00

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 492,300 shares, an increase of 19.9% from the June 30th total of 410,600 shares. Based on an average daily volume of 54,600 shares, the short-interest ratio is presently 9.0 days. Approximately 1.6% of the shares of the stock are short sold.

Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a "strong-buy" rating in a research note on Friday.

Canaccord Genuity Group restated a "buy" rating and issued a $17.00 price objective on shares of Bioceres Crop Solutions in a report on Friday.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totalling 410,600 shares, a growth of 18.4% from the June 15th total of 346,700 shares. Based on an average daily volume of 52,700 shares, the days-to-cover ratio is currently 7.8 days. Currently, 1.3% of the company's stock are short sold.

Bioceres Crop Solutions (NASDAQ:BIOX) Sees Unusually-High Trading Volume

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Investment analysts at Roth Capital issued their FY2024 earnings per share estimates for Bioceres Crop Solutions in a research note issued to investors on Tuesday, July 2nd. Roth Capital analyst S. Fortune anticipates that the company wi

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Equities research analysts at Roth Capital issued their Q3 2025 earnings per share estimates for Bioceres Crop Solutions in a research note issued to investors on Tuesday, July 2nd. Roth Capital analyst S. Fortune forecasts that the comp

Fourth Sail Capital LP boosted its stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 136.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,627,630 shares of the compa

Bioceres Crop Solutions (NASDAQ:BIOX) Shares Up 0.7%

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 301,300 shares, an increase of 12.8% from the April 30th total of 267,100 shares. Based on an average trading volume of 54,400 shares, the short-interest ratio is presently 5.5 days. Currently, 1.0% of the company's stock are sold short.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Stock analysts at Brookline Capital Management boosted their Q4 2024 EPS estimates for shares of Bioceres Crop Solutions in a note issued to investors on Tuesday, May 14th. Brookline Capital Management analyst K. Dolliver now anticipates

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Research analysts at Brookline Capital Management decreased their FY2024 earnings per share estimates for Bioceres Crop Solutions in a research report issued on Tuesday, May 14th. Brookline Capital Management analyst K. Dolliver now anti

Bioceres Crop Solutions (NASDAQ:BIOX) Shares Gap Down to $12.35

Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price Down 2.7%

Bioceres Crop Solutions (NASDAQ:BIOX) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=592731)

Federated Hermes Inc. lowered its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 70.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,524 shares of the company's sto

Fourth Sail Capital LP bought a new position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 689,348 shares of the company's stock, valued at approximately

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 280,500 shares, a drop of 18.1% from the March 31st total of 342,600 shares. Approximately 0.9% of the shares of the company are short sold. Based on an average trading volume of 63,900 shares, the days-to-cover ratio is presently 4.4 days.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 342,600 shares, a growth of 17.7% from the March 15th total of 291,200 shares. Based on an average daily volume of 65,900 shares, the short-interest ratio is currently 5.2 days. Currently, 1.1% of the shares of the stock are short sold.

Polar Capital Holdings Plc bought a new position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 187,032 shares of the company's stock, valued at approximat

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Research analysts at Brookline Capital Management lowered their FY2025 earnings estimates for shares of Bioceres Crop Solutions in a report released on Thursday, February 8th. Brookline Capital Management analyst K. Dolliver now anticipa

Roth Mkm increased their target price on shares of Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a "buy" rating in a research report on Friday.

Bioceres Crop Solutions (NASDAQ:BIOX) Sees Unusually-High Trading Volume on Better-Than-Expected Earnings

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) posted its earnings results on Thursday. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.07 by $0.02. Bioceres Crop Solutions had a return on equity of 3.40% and a net margin of 2.71%. During the same quarter last year, the business earned ($0.14) EPS.

Bioceres Crop Solutions (NASDAQ:BIOX) will be releasing earnings after the market closes on Thursday, February 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=562646)